Cargando…
Novel method of differentiating human induced pluripotent stem cells to mature cardiomyocytes via Sfrp2
Current methods to generate cardiomyocytes from induced pluripotent stem cells (iPSc) utilize broad-spectrum pharmacological inhibitors. These methods give rise to cardiomyocytes which are typically immature. Since we have recently demonstrated that cardiomyogenesis in vitro and in vivo requires Sfr...
Autores principales: | Hsueh, Ying-Chang, Pratt, Richard E., Dzau, Victor J., Hodgkinson, Conrad P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998650/ https://www.ncbi.nlm.nih.gov/pubmed/36894665 http://dx.doi.org/10.1038/s41598-023-31144-3 |
Ejemplares similares
-
The role of Sfrp and DKK proteins in cardiomyocyte development
por: Hsueh, Ying‐Chang, et al.
Publicado: (2021) -
Induced cardiomyocyte maturation: Cardiac transcription factors are necessary but not sufficient
por: Dal-Pra, Sophie, et al.
Publicado: (2019) -
Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog
por: Wang, Xiaowen, et al.
Publicado: (2016) -
Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes
por: Machiraju, Pranav, et al.
Publicado: (2019) -
Neonatal and adult cardiac fibroblasts exhibit inherent differences in cardiac regenerative capacity
por: Sun, Hualing, et al.
Publicado: (2023)